Sebastião Ana Isabel, Ferreira Isabel, Brites Gonçalo, Silva Ana, Neves Bruno Miguel, Teresa Cruz Maria
Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
Pharmaceutics. 2020 Sep 11;12(9):867. doi: 10.3390/pharmaceutics12090867.
Allergic contact dermatitis is a common occupational disease that manifests as a cell-mediated hypersensitivity reaction following skin exposure to small reactive chemicals termed haptens. Haptens penetrate the stratum corneum and covalently modify proteins in the epidermis, inducing intracellular stress, which further leads to the release of damage-associated molecular patterns (DAMPs), such as uric acid, reactive oxygen species, hyaluronic acid fragments and extracellular adenosine triphosphate (ATP). These DAMPs are recognized by pattern recognition receptors (PRRs) in innate immune cells, namely dendritic cells (DCs), leading to their maturation and migration to the draining lymph nodes where they activate naïve T lymphocytes. Among all PRRs, several studies emphasize the role of NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome on the allergic contact dermatitis (ACD) sensitization phase. However, skin allergens-danger signals-NLRP3 inflammasome axis is yet to be completely elucidated. Therefore, in this review, we sought to discuss the molecular mechanisms underlying DAMPs release and NLRP3 inflammasome activation triggered by skin allergens. The elucidation of these key events might help to identify novel therapeutic strategies for ACD, as well as the development of nonanimal alternative methods for the identification and potency categorization of skin sensitizers.
过敏性接触性皮炎是一种常见的职业病,表现为皮肤接触称为半抗原的小反应性化学物质后发生的细胞介导的超敏反应。半抗原穿透角质层并与表皮中的蛋白质共价修饰,诱导细胞内应激,进而导致损伤相关分子模式(DAMPs)的释放,如尿酸、活性氧、透明质酸片段和细胞外三磷酸腺苷(ATP)。这些DAMPs被天然免疫细胞即树突状细胞(DCs)中的模式识别受体(PRRs)识别,导致其成熟并迁移至引流淋巴结,在那里它们激活幼稚T淋巴细胞。在所有PRRs中,多项研究强调含NOD、LRR和pyrin结构域蛋白3(NLRP3)炎性小体在过敏性接触性皮炎(ACD)致敏阶段的作用。然而,皮肤过敏原-危险信号-NLRP3炎性小体轴尚未完全阐明。因此,在本综述中,我们试图讨论皮肤过敏原引发的DAMPs释放和NLRP3炎性小体激活的分子机制。阐明这些关键事件可能有助于确定ACD的新型治疗策略,以及开发用于鉴定皮肤致敏剂及其效力分类的非动物替代方法。